In Silico Product Development in the Healthcare Industry Seminar

September 6, 2017

6:00 PM - 8:00 PM (PDT)


Wolf Creek Restaurant and Brewing Company
27746 McBean Parkway
Valencia, CA 91354

Tenny Kachatourian

Max Singleton

In silico product development (i.e. computer modeling and simulation) is revolutionizing the healthcare industry. The methodology provides valuable insights upfront, resulting in earlier product launch dates, extreme product safety and reliability, and greater return on investment, through reduced reliance on bench testing and animal studies, as well as greater successes in clinical trials. In silico testing is recognized by the US FDA as a fourth pillar of pre-market evaluation. Innovative companies are also leveraging in silico tools for personalized medicine.

Join us for an evening event and dinner as we discuss how a multi-domain digital system prototyping platform enables multispecialty teams with diverse engineering backgrounds to work in unison to achieve a deep understanding of integrated product behavior.


Welcome and Introduction to ANSYS
ANSYS in the Healthcare Industry
Regulatory Update
  • Overview of the current regulatory pathway for computational model results in device submissions.
  • Case Studies
  • Incubator Design
  • MRI Coil Modeling and Human Phantoms with Demonstration
  • System Modeling with Demonstration

  • These case studies will review the use of computational modeling tools to improve product design, understand the interactions between the human body and the RF environment inside an MRI coil, and demonstrate how the ANSYS platform can enable multi-physics, multi-scale system-level modeling to model the drug delivery sub-system of an insulin pump.

    Guest Speaker

    Marc Horner, Ph.D.

    Technical Lead, Healthcare


    Dr. Marc Horner is currently working as lead healthcare specialist at ANSYS, Inc. Marc joined ANSYS after earning his Ph.D. in Chemical Engineering from Northwestern University in 2001. Marc began by providing support and professional services for biomedical clients, primarily in the areas of cardiovascular devices, drug delivery, packaging, electro-separation, microfluidics and orthopaedics. During this time, Marc developed numerous modeling approaches that can be used to establish the safety and efficacy of medical devices. Marc now helps coordinate ANSYS business and technology development for the healthcare sector in North America. This includes managing collaborative research projects between ANSYS and industry, academia, and the US FDA.

    Marc is Vice Chair of the ASME V&V40 Sub-Committee - which is establishing V&V best practices for the medical device industry, and the ASME V&V Standards Committee - who oversee the creation of best practices and general guidance on V&V for computational modeling and simulation. Marc is also an Associate Editor of the ASME Journal of Verification, Validation, and Uncertainty Quantification. Lastly, Marc is an Executive Committee Member of the IMAG/MSM Credible Practice of Modeling & Simulation in Healthcare project. This group aims to establish a task-oriented collaborative platform to outline good practice of simulation-based medicine.